Endexx Corporation (EDXC)
OTCMKTS · Delayed Price · Currency is USD
0.0050
+0.0004 (8.70%)
Aug 19, 2025, 3:56 PM EDT
Endexx Market Cap
Endexx has a market cap or net worth of $2.73 million as of August 19, 2025. Its market cap has decreased by -68.28% in one year.
Market Cap
2.73M
Enterprise Value
n/a
Revenue
4.64M
Ranking
n/a
PE Ratio
0.34
Stock Price
$0.01
Market Cap Chart
Since January 2, 2015, Endexx's market cap has decreased from 9.53M to 2.73M, a decrease of -71.34%. That is a compound annual growth rate of -11.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 2.73M | -30.73% |
| Dec 31, 2024 | 3.94M | -55.52% |
| Dec 29, 2023 | 8.86M | -61.70% |
| Dec 30, 2022 | 23.13M | 54.09% |
| Dec 31, 2021 | 15.01M | -63.78% |
| Dec 31, 2020 | 41.45M | 21.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |